Clinical trial Recruiting at 1 site Observational Ages 18 and up

Restor3D Outcomes Registry: Patient-specific Joint Implants

Official title: The restor3d Outcomes Registry: Tracking Patient Recovery After Joint Replacement

Run by Restor3D · NCT07563803 · Data updated 2026-11-12

This registry tests how patients with FDA-cleared restor3d patient-specific implants fare over up to 5 years, by collecting their own reports on pain, function and quality of life after joint replacement surgeries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2250 (estimated)
SponsorRestor3D
Industry-sponsored
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedOctober 15, 2032
Study endsOctober 15, 2032
Registry record updatedOctober 27, 2026
Trial IDNCT07563803 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who have been prescribed and received an FDA-cleared or approved restor3d patient-specific orthopedic implant and consent to participate, with English proficiency.

Probably not a fit

Patients receiving non–restor3d implants, implants not FDA-cleared/approved, outside the defined cohorts, or who do not consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The restor3d Outcomes Registry is a prospective, decentralized, longitudinal observational study enrolling adults who have received a restor3d patient-specific orthopedic implant across multiple joint cohorts (knee, hip, foot & ankle, shoulder). Participants complete electronic patient-reported outcomes before surgery and at defined intervals up to five years postoperatively, without in-person visits. The study uses a master protocol with joint-specific appendices to standardize data collection and aims to quantify changes in pain, function, quality of life, and satisfaction while establishing real-world benchmarks for these implants. Enrollment is limited to US-based patients receiving FDA-cleared or approved restor3d implants and who speak English to ensure accurate survey completion. Lead sponsor is Restor3D, with no collaborators and a single participating site in Durham, NC.

Why it matters

Potential benefit: If successful, the registry could provide real-world benchmarks for patient-specific implants and help guide future clinical decisions and patient expectations.

How similar studies have gone: Other real-world, patient-reported outcomes registries for orthopedic implants have shown value in tracking long-term outcomes, though this program appears to be specific to restor3d patient-specific implants.

Who can join: the full rules

Show full inclusion / exclusion criteria
Master Protocol Inclusion Criteria:

* Age ≥ 18 years
* Prescribed an FDA-cleared or approved orthopedic implant manufactured by restor3d, Inc.

Master Protocol Exclusion Criteria:

* Patient is receiving an implant not manufactured by restor3d
* Patient is receiving a restor3d implant that is not FDA-cleared or approved
* Patient lives outside the United States
* Patient is receiving a restor3d implant that does not use a patient-specific plan, instrumentation or implant
* Patient is non-English-speaking (to ensure accurate comprehension and completion of the surveys)
* Patient is receiving a restor3d implant outside of the defined implant cohorts
* Patient does not provide informed consent

Where it's running

  • Restor3D
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.